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The coronavirus disease 2019 (COVID-19) outbreak has been designated as a 
worldwide pandemic by World Health Organization (WHO) and raised an inter-
national call for global health emergency. In this regard, recent advancements of 
technologies in the field of artificial intelligence and machine learning provide 
opportunities for researchers and scientists to step in this battlefield and convert the 
related data into a meaningful knowledge through computational-based models, for 
the task of containment the virus, diagnosis and providing treatment. In this study, 
we will provide recent developments and practical implementations of artificial 
intelligence modeling and machine learning algorithms proposed by researchers 
and practitioners during the pandemic period which suggest serious potential in 
compliant solutions for investigating diagnosis and decision making using comput-
erized tomography (CT) scan imaging. We will review the modern algorithms in CT 
scan imaging modeling that may be used for detection, quantification, and tracking 
of Coronavirus and study how they can differentiate Coronavirus patients from 
those who do not have the disease.
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1. Introduction
Today, the world is facing one of its most dangerous risks, if not the most one 
throughout the century. It is a pandemic that is draining the whole world’s resources 
and threatening the development of human civilization. The COVID-19 pandemic 
continues to have a devastating effect on the health and well-being of global 
population, caused by the infection of individuals by the severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) [1]. On the 30th of January 2020, the WHO 
declared the SARS-CoV-2 outbreak a public health emergency of international 
concern. On March 11th, WHO characterized COVID-19 as a pandemic. At the time 
of writing this manuscript (May 29, 2021), the number of infected people has sur-
passed 169,118,995 confirmed cases and more than 3,519,175 deaths in 223 countries 
[2]. The World Trade Organization has announced that the world has effectively 
entered a recession period. The world’s economy and many countries’ economies are 
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in danger of collapsing. Schools in many countries are closed and students around 
the world are forced to stay at home [3, 4].
One of the early challenges that emerged at the beginning of the pandemic is 
the detection of COVID-19 cases. The most important method used for detect-
ing COVID-19 cases is polymerase chain reaction (PCR) testing, that can detect 
SARSCoV-2 RNA from respiratory specimens [5]. Though PCR testing is the 
standard, it is a time-consuming, laborious, and complicated manual process that 
is in short supply [6]. Accurate and rapid diagnosis of COVID-19 suspected cases 
plays a crucial role in timely quarantine and medical treatment. This limitation 
of human expert-based diagnosis has provided a strong motivation for the use of 
computer simulation and modeling to improve the speed and accuracy of the detec-
tion process [7, 8]. Another related issue is the manual contouring of lung lesions 
which tends to be a tedious and time-consuming work, and could lead to subse-
quent assessment discrepancies in case of inconsistent delineation. Thus, a fast 
auto-contouring tool for COVID-19 infection is needed in the onsite applications for 
quantitative disease assessment [9].
Since the early days of this catastrophic crisis, there has been an upsurge in the 
exploration and use of artificial intelligence (AI), computer simulation, and data 
modeling and analytic tools, in a multitude of areas. AI and machine learning (ML) 
have demonstrated great performance in various medical fields and have proven 
their vital role in complicated therapeutic scenes. These systems have shown high 
level of accuracy in different applications, such as lung disease classification, breast 
cancer, skin lesion classification, identifying diabetic retinopathy, and Alzheimer 
[10–12].
Scientists and healthcare professionals have realized the importance of AI and 
imaging technologies in slowing the spread of COVID-19 at preliminary stages, and 
containing the virus at later stages. Currently, many AI and computer modeling 
systems are used in disease diagnosis, examining, identifying, and treating patients. 
AI-based simulations have also been employed for evaluating disease progression, 
economic downturn and recovery, contingency planning, demand sensing, supply 
chain disruptions, workforce planning, as well as for management decision-making 
on site openings [13]. For example, AI-based simulations were critical in integrating 
multiple decision-making domains (e.g., COVID-19 disease progression, govern-
ment interventions, people behavior, demand sensing, supply disruptions etc.) [14].
In this paper, we provide an extensive review and a deep study on how AI and 
ML can help the world to deliver efficient responses and combat the COVID-19 
pandemic using CT scan imaging. More specifically, we will focus on the modern 
algorithms in CT scan imaging that may be used for detection, quantification, 
and tracking of Coronavirus and study how they can differentiate Coronavirus 
patients from those who do not have the disease. We provide recent theoretical 
developments, technological advancements, and practical implementations of AI 
algorithms and ML techniques that uses CT imaging to suggest possible solutions in 
investigating diagnosis, severity level, prediction, tracking, treatments and other 
decision making scenarios related to COVID-19. In this regard, we explore a vast 
number of important studies that have been performed by various academic and 
research communities from numerous disciplines during the period of pandemic 
since the early days of 2020 up to the very recent days (May 2021). Before we fur-
ther proceed, we note that many of the articles cited are still preprints at the time of 
writing this manuscript. Given the fast-moving nature of the crisis, we endeavored 
to be comprehensive of coverage. We understand that the full scientific rigor for 
many articles should still be assessed by the scientific community through peer-
reviewed evaluation and other quality control mechanisms. However, the whole 
story is a striking dilemma and a big challenge to the global scientific communities. 
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Researchers, physicians, technical-background individuals, and academics are 
putting all their efforts to come up with solutions and cures to this fatal disease. All 
of these efforts have emerged during a very short period of time, and a lot are yet to 
emerge in the coming few months, and possibly years.
1.1 A view of AI and ML in healthcare
AI is becoming one of the highest priorities for healthcare decision makers, 
governments, investors and innovators. An increasing number of governments 
have set out targets for AI in healthcare, in countries as diverse as the United States, 
China, Finland, Germany, and the UK, and many are investing heavily in AI-related 
research. The private sector is also playing a significant role, with venture capital 
funding for the top 50 firms in healthcare-related AI reaching $8.5 billion [15]. 
Though the US dominates the list of firms with highest venture capital funding in 
healthcare AI to date, and has the most related research studies and trials, China is 
emerging as the fastest growing country in this field. Europe, meanwhile, benefits 
from the vast depot of health data collected by national health systems and has 
significant strengths in terms of the number of research studies, established clusters 
of innovation and collaborations related to AI [16].
AI applications based on imaging, are already in use in specialties such as 
radiology, oncology, cardiology, neurology, pathology and ophthalmology. It is 
expected that more AI solutions would support the shift from hospital-based to 
home-based care, such as remote monitoring, AI-powered alerting systems, and 
virtual assistants [17, 18]. Also, AI is anticipated to be embedded more extensively 
in clinical workflows through the intensive engagement of professional bodies and 
providers. Moreover, AI solutions are expected to emerge in clinical practices based 
on evidence from clinical trials, with increasing focus on improved and scaled clini-
cal decision-support tools [19]. Advances in AI mean that algorithms can generate 
layers of abstract features that enable computers to recognize complicated concepts 
(such as a diagnosis). This enables them to learn discriminative features automati-
cally and approximate highly complex relationships [20, 21].
2. Convolutional neural network
Neural networks have been successfully applied to many real-world problems. The 
most general type of neural network is Multilayer Perceptron (MLP). While MLPs 
can be used to effectively classify small images, they are impractical for large images. 
The reason for this can be explained by the fact that the implementation of a MLP 
would result in a huge output vector of weights for each class (size of millions). MLPs 
not only are computationally expensive to train (both in terms of time and memory 
usage), but they also have high variance due to the large number of weights [22, 23].
Convolutional Neural Networks (CNNs) have been driving the heart of com-
puter vision in recent years. The key concept of CNNs is to find local features from 
an input (usually an image) at higher layers and combine them into more multi-
faceted features at lower layers [24, 25]. CNNs are very good in extracting patterns 
in the input image, such as lines, gradients, circles, or even eyes and faces. It is this 
property that makes CNNs so powerful for computer vision. Unlike earlier com-
puter vision algorithms, CNNs can operate directly on a raw image and do not need 
any preprocessing. In the medical field, CNNs are used to improve image quality 
in low-light images from a high-speed video endoscopy [26] and is also applied to 
recognize the nature of pulmonary nodules via CT images and the identification of 
pediatric pneumonia via chest X-ray images [27].
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A CNN comprises several layers where each neuron of a subsequent higher layer 
connects to a subset of neurons in the previous lower layer. This permits the recep-
tive field of a neuron of a higher layer to cover a greater part of images compared to 
that of a lower layer. The higher layer is capable to learn more abstract features of 
images than the lower layer by considering the spatial relationships between differ-
ent receptive fields. It should be noted that CNNs significantly reduce the number 
of weights, and in turn reduce the variance. Like MLPs, CNNs use fully connected 
(FC) layers and non-linearities, but they introduce two new types of layers: convo-
lutional and pooling layers. A convolutional layer takes a W × H × D dimensional 
input “I” and convolves it with a w × h × D dimensional filter (or kernel) G. The 
weights of the filter can be hand designed, but in the context of machine learning 
they are automatically tuned, just like the way weights of an FC layer are tuned. In 
line with convolutional layers where reducing the number of weights in neural net-
works reduces the variance, pooling layers directly reduce the number of neurons in 
neural networks. The sole purpose of a pooling layer is to downsample (also known 
as pool, gather, consolidate) the previous layer, by sliding a fixed window across a 
layer and choosing one value that effectively “represents” all of the units captured 
by the window. There are two common implementations of pooling. In max-pool-
ing, the representative value just becomes the largest of all the units in the window, 
while in average-pooling, the representative value is the average of all the units in 
the window. In practice, pooling layers are stridden across the image with the stride 
equal to the size of the pooling layer. None of these properties actually involve any 
weights, unlike fully connected and convolutional layers.
3. CT diagnosis algorithms
Medical imaging is a useful supplement to reverse transcription polymerase 
chain reaction (RT-PCR) testing for the confirmation of COVID-19. Researchers 
have found that CT images of COVID-19 patients exhibit typical imaging charac-
teristics. During the last year, studies have shown that typical chest CT patterns of 
COVID-19 viral pneumonia include multifocal bilateral peripheral ground-glass 
areas associated with subsegmental patchy consolidations, mostly subpleural, 
and predominantly involving lower lung lobes and posterior segments [28–32]. In 
more detail, chest CT images of COVID-19 patients could be evaluated using the 
following characteristics [33–40]:
• presence of ground-glass opacities (GGOs)
• laterality of GGO and consolidation
• presence of nodules
• presence of pleural effusion
• presence of thoracic lymphadenopathy
• degree of involvement of each lung lobe, in addition to the overall extent of 
lung involvement measured
• presence of underlying lung disease such as emphysema or fibrosis
• bilateral distribution
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• number of lobes affected where either ground-glass or consolidative opacities 
are present
• interlobular septal thickening
• presence of cavitation
• bronchial wall thickening
• air bronchogram
• perilesional vessel diameter
• lymphadenopathy
• pleural pericardial effusion
GGO, which is defined as hazy increased lung attenuation with preservation of 
bronchial and vascular margins [41], is the most common early finding of COVID-
19 on chest CT. Besides GGO, bilateral patchy shadowing is one of the most com-
mon radiologic findings on chest CT [42]. In another study containing 51 COVID-19 
patients, Song et al. [43] found that disease progression can be determined by 
lesions with consolidation. Multiple lesions and crazy-paving pattern are also com-
mon in COVID-19 patients. The diagnosis of chest CT depending on visual diagno-
sis of radiologists suffers from some problems [44]. For example, chest CT contains 
hundreds of slices, which takes a long time to diagnose. Also, it was found that the 
chest CT images of some COVID-19 patients share some similar manifestations 
with other types of pneumonia. This could add extra challenges to inexperienced 
radiologists, considering that COVID-19 is a new lung disease.
During the last year, AI methods and ML techniques have played a very impor-
tant role in COVID-19 diagnosis in applications utilizing the CT imaging. The aim 
of AI techniques and ML methods was always to extract the distinguished features 
of COVID-19 presented in the different types of images. In this section, we review 
and thoroughly discuss the major works and articles that have addressed AI and 
ML in COVID-19 diagnosis using CT imagery. AI and deep learning methods have 
shown great ability to address the aforementioned problems by detecting this dis-
ease and distinguishing it from community acquired pneumonia (CAP) and other 
non-pneumonic lung diseases using chest CT. We explore important studies that 
have been performed by various academic and research communities from numer-
ous disciplines which focus on detecting, quantifying, and tracking of Coronavirus 
and study how they can differentiate Coronavirus patients from those who do not 
have the disease.
Li et al. [45] developed a 3D deep learning framework for the detection of 
COVID-19, referred to as COVID-19 detection neural network (COVNet). The 
proposed CNN consists of a RestNet50 as the backbone, which takes a series of 
CT slices as the input and generates features for the corresponding slices. In more 
detail, it extracts visual features from volumetric chest CT scans both in 2D local 
and 3D global representation. The extracted features from all slices are then com-
bined by a max-pooling operation. CAP and other non-pneumonia CT scans were 
included to test the robustness of the proposed model. The final feature map is fed 
to a fully connected layer and softmax activation function to generate a probability 
score for each type (COVID-19, CAP, and non-pneumonia), and produce a classifi-
cation prediction. The CT scans are performed using different manufacturers with 
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standard imaging protocols. Each volumetric scan contains 1094 CT slices with a 
varying slice-thickness from 0.5 mm to 3 mm. The reconstruction matrix is 512x512 
pixels with in-plane pixel spatial resolution from 0.29x0.29 mm2 to 0.98x0.98 mm2. 
The CT scans are preprocessed and the lung region is extracted as the region of 
interest (ROI) using a U-net based segmentation method. Then, the image is passed 
to the COVNet for the predictions, as shown in Figure 1.
The authors have tested the system on datasets collected from six hospitals 
between August 2016 and February 2020. The collected datasets consisted of 4356 
chest CT scans from 3322 patients. Diagnostic performance was assessed by the area 
under the receiver operating characteristic curve (AUC), sensitivity and specificity. 
The COVID-19 cases were affirmed as positive by RT-PCR and were obtained from 
Dec 31, 2019 to Feb 17, 2020. The most shared symptoms were fever (81%) and 
cough (66%). Moreover, the patients were 49±15 years old and there are slightly 
more male patients than female (1838 vs. 1484). CT scans with multiple reconstruc-
tion kernels at the same imaging session or acquired at multiple time points were 
included. The final dataset consisted of 1296 (30%) scans for COVID-19, 1735 
(40%) for CAP and 1325 (30%) for non-pneumonia.
For each patient, one or multiple CT scans at several time points during the 
course of the disease were acquired (Average CT scans per patient was 1.8, with a 
range from 1 to 6). The per-scan sensitivity and specificity for detecting COVID-19 
in the independent test set was 114 of 127 (90% [95% confidence interval: 83%, 
94%]) and 294 of 307 (96% [95% confidence interval: 93%, 98%]), respectively, 
with an AUC of 0.96. The details of their tests are given in Table 1.
In another study, a weakly-supervised deep learning-based software system 
was developed by Zheng et al. [46] using 3D CT volumes to detect COVID-19. 
The authors have searched unenhanced chest CT scans of patients with suspected 
COVID-19 from the picture archiving and communication system of radiology 
department (Union Hospital, Tongji Medical College, Huazhong University of 
Figure 1. 
COVID-19 detection neural network (COVNet) architecture [45].
Sensitivity % Specificity % AUC
COVID-19 90 (114 of 127) 96 (294 of 307) 0.96
CAP 87 (152 of 175) 92 (239 of 259) 0.95
Non-Pneumonia 94 (124 of 132) 96 (291 of 302) 0.98
Note: Values in the parentheses are the numbers for the percentage calculations.
Table 1. 
The performance of COVNet as per [45].
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Science and Technology). 540 patients (age of 42.5 ± 16.1 years; range 3–81 years) 
were enrolled into the study, including 313 patients (age, 50.7 ± 14.7 years; range 
8–81 years) with clinical diagnosed COVID-19 (COVID-positive group) and 227 
patients (age of 31.2 ± 10.0 years; range, 3–69 years) without COVID-19 (COVID-
negative group). As shown in Figure 2, the system takes a CT volume and its 3D 
lung mask as input, where the 3D lung mask is generated by a pre-trained U-Net. 
The proposed system is divided into three stages. The first stage consists of a 3D 
convolution with a kernel size of 5 × 7 × 7, a batchnorm layer and a pooling layer. 
The second stage is composed of two 3D residual blocks. In each one of the residual 
block, a 3D feature map is handed into both a 3D convolution with a batchnorm 
layer and a shorter connection containing a 3D convolution. The third stage is 
a progressive classifier, which contains three 3D convolution layers and a fully-
connected layer with the softmax activation function. As described in Figure 3, a 
U-Net is trained for lung region segmentation on the labeled training set using the 
ground-truth lung masks generated by an unsupervised learning method. Then, the 
pre-trained U-Net is used to test all CT volumes to obtain the lung masks. The lung 
mask is concatenated with CT volume and serves as the input of the system. The 
authors have used the spatially global pooling layer and the temporally global pool-
ing layer to technically handle the weakly-supervised COVID-19 detection problem.
Furthermore, Gozes et al. [47] presented a system that exploits 2D and 3D deep 
learning models. Figure 4 shows a block diagram of the developed system. The 
system is comprised of several components and analyzes the CT case at two distinct 
levels: Subsystem A and Subsystem B. Subsystem A provides a 3D analysis of the case 
volume for nodules and focal opacities using existing, previously developed algo-
rithms, where Subsystem B provides newly developed 2D analysis of each slice of 
Figure 2. 
The architecture proposed in [46]. The network takes a CT volume with its 3D lung mask as the input and 
outputs the probabilities of COVID-19 positive/negative.
Figure 3. 
Training and testing procedures [46].
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the case to detect and localize larger-sized diffuse opacities including ground glass 
infiltrates which have been clinically described as representative of Coronavirus. 
As argued by the authors, working in the 2D space has several advantages for deep 
learning based algorithms in limited data scenarios. These include an increase in the 
training samples (with many slices per single case), the ability to use pre-trained 
networks that are common in 2D space, and an easier annotation for segmentation 
purposes.
For Subsystem A, the authors used commercial off-the-shelf software that 
detects nodules and small opacities within a 3D lung volume. This software was 
developed as a solution for lung pathology detection and provides quantitative 
measurements (including volumetric measurements, axial measurements, calci-
fication detection and texture characterization). For Subsystem B, the first step 
is the lung crop stage, where the lung region of interest is extracted using a lung 
segmentation module. In the following step, Coronavirus related abnormalities are 
detected using Resnet-50, which is a 2D CNN architecture that consists of 50 layers. 
In the classification stage, the authors calculated the ratio of positive detected slices 
out of the total slices of the lung (positive ratio). A positive case-decision is made 
if the positive ratio exceeds a pre-defined threshold. The system was tested on 157 
patients from China and U.S. The sensitivity and the specificity of the system were 
98.2% and 92.2%, respectively. Figure 5 shows a patient case visualization.
The authors have also proposed a Corona score which is a volumetric measurement 
of the opacities burden. The corona score is computed by a volumetric summation of 
the network-activation maps. The system output enables quantitative measurements 
for smaller opacities (volume, diameter) and visualization of the larger opacities in 
a slice-based “heat map” or a 3D volume display. The authors claim that the score is 
robust to slice thickness and pixel spacing as it includes pixel volume. For patient-
specific monitoring of disease progression, they suggested the Relative Corona score 
in which they normalize the corona score by the score computed at the first time 
point. The suggested “Corona score” measures the progression of disease over time. 
An example of such an implementation is shown in Figure 6 which demonstrates 
a tracking over time of a specific opacity in a Coronavirus patient (red box). In this 
example, a patient was imaged in time points where the first CT scan was obtained 
few days following the first signs of the virus (fever, cough). This case involves 
multiple opacities and shows an overview of the patient recovery process with its 
corresponding Corona score over time.
Barstugan et al. [48] presented a classification system consisting of five differ-
ent feature extraction methods followed by support vector machine (SVM). The 
feature extraction methods were Gray Level Co-occurrence Matrix (GLCM), Local 
Figure 4. 
System block diagram [47].
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Directional Patterns (LDP), Gray Level Run Length Matrix (GLRLM), Gray Level 
Size Zone Matrix (GLSZM), and Discrete Wavelet Transform (DWT). To test the 
proposed system, four different datasets were formed by taking patches of size 
16x16, 32x32, 48x48 and 64x64 from 150 CT images belonging to 53 infected cases, 
from the “Societa Italiana di Radiologia Medica e Interventistica”. The samples of 
datasets were labeled as Coronavirus/non-Coronavirus (infected/non-infected). 
Table 2 shows the four different subsets created from patch regions. The authors 
have implemented 2-fold, 5-fold and 10-fold cross-validations during the classifica-
tion process. Sensitivity, specificity, accuracy, precision, and F-score metrics were 
used to evaluate the classification performance. Figure 7 shows patch regions and 
patch samples from the four different subsets.
Caruso et al. [49] investigated chest CT features of patients with COVID-19 in 
Rome, Italy, and compared the diagnostic performance of CT with that of RT-PCR. 
All chest CT examinations were performed with patients in the supine position on 
a 128-slice CT scanner. Radiologists in consensus with thoracic imaging experience 
evaluated the images using a clinically available dedicated application (Thoracic 
VCAR, GE Medical Systems), defining patients as having positive CT findings when 
a diagnosis of viral pneumonia was reported. The study comprised 158 participants, 
of them fever was witnessed in 97 (61%) and cough and dyspnea were observed 
in 88 (56%) and 52 (33%), respectively. Of these patients, 62 (39%) had positive 
RT-PCR results and 102 (64%) had positive CT findings. Sensitivity, specificity, and 
accuracy of CT for COVID-19 pneumonia were 97% (60 of 62 participants), 56% 
(54 of 96 participants), and 72% (114 of 158 participants), respectively.
Table 3 details the CT features in participants with COVID-19 infection con-
firmed with RT-PCR as reported in [49]. The results presented in [49] agree with 
Figure 6. 
Multi time point tracking of disease progression [47].
Figure 5. 
Patient case visualization. Left: Coronal view; right: Automatically generated 3D volume map of focal 
opacities (green) and larger diffuse opacities (red) [47].
Simulation Modelling
10
the study performed by Salehi et al. [50] of 919 patients, despite some differences. 
However, the population in [50] varies from the population examined in [49]. Also, 
Chung et al. [51] analyzed a small population consisting of 21 patients and found a 
very low frequency of crazy paving pattern compared with [49] (19% vs. 39%).
Furthermore, Xu et al. [52] established a model to distinguish COVID-19 from 
influenza-A viral pneumonia (IAVP) and healthy cases through pulmonary CT 
images. The authors have discussed that the RT-PCR detection of viral RNA from 
sputum or nasopharyngeal swab have a relatively low positive rate in the early 
stage. They argued that the manifestations of COVID-19 as seen through CT 
imaging show individual characteristics that differ from those of other types of 
viral pneumonia such as IAVP. The suggested model consists of multiple CNNs, 
where the candidate infection regions are segmented out from the pulmonary 
CT image set. Then, these separated images are categorized into the COVID-
19, IAVP, and irrelevant to infection groups, together with the corresponding 
confidence scores, using a location-attention classification model. Finally, the 
infection type and overall confidence score for each CT case are calculated using 
the Noisy-OR Bayesian function.
Figure 8 shows the whole process. As described in the figure, the CT images are 
first preprocessed to excavate the effective pulmonary regions. Then, a 3D CNN 
segmentation model is used to segment multiple candidate image cubes. After that, 
an image classification model is used to classify all the image patches into three 
Figure 7. 
Patch regions and patch samples from the four different subsets. Sample images for infected and non-infected 
situations for all subsets are shown as well [48].
Subset Patch  
Dimension
Number of Non-Coronavirus 
Patches
Number of Coronavirus 
Patches
Subset 1 16 × 16 5912 6940
Subset 2 32 × 32 942 1122
Subset 3 48 × 48 255 306
Subset 4 64 × 64 76 107
Table 2. 
Four different subsets created from patch regions [48].
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kinds: COVID-19, IAVP, and irrelevant to infection. Image patches from the same 
group “vote” for the type and confidence score of this candidate as a whole. Finally, 
the Noisy-OR Bayesian function is used to calculate the overall analysis report for 
one CT sample. It is worth mentioning that the model uses a V-Net as the backbone 
feature extraction part. The authors have further discussed how the variable 3D 
structures of the lesion regions can aggravate the results. For example, when the 
border between a healthy region and the infected one becomes blurred and indis-
tinct, it will be difficult to label pixel-level masks for lesion regions of pneumonia. 
As such, the model uses the RPN structure [52] to capture the region of interest 
with 3D bounding boxes instead of pixel-level segmented masks.
Figure 8. 
The process flow chart of [52].
CT Feature No. of Participants (n = 58) Percentage
GGO 58 100
Multilobe involvement (≥2 lobes) 54 93
Bilateral distribution 53 91
Posterior involvement 54 93
GGO location (peripheral) 52 89






Air bronchogram 21 36
Pulmonary nodules surrounded by GGO 10 17
Interlobular septal thickening 8 13
Halo sign 7 12
Pericardial effusion 3 5
Pleural effusion 2 3
Bronchial wall thickening 1 1
Cavitation 0 0
Table 3. 
CT features in participants with COVID-19 infection confirmed with RT-PCR [49].
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To evaluate the system, two classification models were used, as shown in 
Figure 9. The first one was the ResNet model and the other was designed based on 
the first network structure by concatenating the location-attention mechanism in 
the full-connection layer to improve the overall accuracy rate. The resultant model 
was added to the first full-connection layer to enhance the influence of this factor 
on the whole network. The output of the convolution layer was flattened to a 
256-dimensional feature vector and then converted into a 16-dimensional feature 
vector using a full-connection network. The overall accuracy rate was 86.7% in 
terms of all the CT cases taken together.
Belfiore et al. [53] presented a practice of a good tool for radiologists (Thoracic 
VCAR) that can be used in COVID-19 diagnosis. Thoracic VCAR offers quantitative 
measurements of the lung involvement. Further, it can generate a clear, fast and 
concise report that communicates vital medical information to referring physi-
cians. In the post-processing phase, the software can recognize the ground glass 
and differentiate it from consolidation and quantifies them as a percentage with 
respect to the healthy parenchyma. This information is useful for evaluating regres-
sion or progression disease in response to drug therapy as well as evaluating the 
effectiveness of pronation maneuvers for alveolar recruitment in ICU patients. The 
authors in [53] have discussed the importance of such high-resolution CT (HRCT) 
technique in investigating the patients with suspicion COVID-19 pneumonia. They 
have argued that the HRCT is a very accurate technique in identifying pathognomic 
findings of interstitial pneumonia as ground glass areas, crazy paving, nodules and 
consolidations, mono- or bilateral, patchy or multifocal, central and/or peripheral 
distribution, declivous or nondeclivous. As per the discussion, during the follow-
up, HRCT examination can quantify the course of the disease and evaluate the 
effectiveness of the experimental trial and the patient’s prognosis.
In [54], Mei et al. have also used AI algorithms to integrate chest CT find-
ings with clinical symptoms, exposure history and laboratory testing to rapidly 
diagnose patients who are positive for COVID-19. Among a total of 905 patients 
Figure 9. 
The network structure of ResNet-18-based classification model [52].
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tested by real-time RT–PCR test, 419 (46.3%) tested positive for SARS-CoV-2. 
In this study, the dataset included patients aged from 1 to 91 years (with mean 
of 40.7 year and standard deviation of 6.5 years) where 488 of the patients were 
men and 417 were women. All scans were acquired using a standard chest CT 
protocol and were reconstructed using the multiple kernels and displayed with a 
lung window. Clinical information included travel and exposure history, leu-
kocyte counts (including absolute neutrophil number, percentage neutrophils, 
absolute lymphocyte number and percentage lymphocytes), symptomatology 
(presence of fever, cough and sputum), patient age and patient sex. More spe-
cifically, the authors developed a CNN to learn the imaging characteristics of 
patients on the initial CT scan. They used multilayer perceptron classifiers to 
classify patients with COVID-19 according to the radiological data and clinical 
information.
Of the 134 positive cases in the test set, 90 were correctly categorized by both 
the joint model and the senior thoracic radiologist and 33 were classified differently. 
Of the 33 patients, 23 were correctly classified as positive by the joint model, but 
were misclassified by the senior thoracic radiologist. Ten patients were classified as 
negative by the joint model, but correctly diagnosed by the senior thoracic radiolo-
gist. Eleven patients were misclassified by both the joint model and the senior 
thoracic radiologist. Of the 145 patients negative for COVID-19 in the test set, 113 
were correctly classified by both the joint model and the senior thoracic radiologist. 
Thirty-two out of 145 were classified differently by the joint model and the senior 
thoracic radiologist. Seven were correctly classified as negative by the joint model, 
but were diagnosed as positive by the senior thoracic radiologist. Twenty-three were 
classified as positive by the joint model, but correctly diagnosed as negative by the 
senior thoracic radiologist. Two patients were misclassified by both the joint model 
and the senior thoracic radiologist. As discussed in [54], patient’s age, presence 
of exposure to SARS-CoV-2, presence of fever, cough, cough with sputum, and 
white blood cell counts are significant features associated with SARS-CoV-2 status. 
However, it should be pointed out that difficulties on model training have been 
witnessed due to the limited sample size.
Moreover, Fei et al. [55] developed a deep learning-based system for automatic 
segmentation of lung and infection sites using chest CT. Likewise, Xiaowei et al. 
[56] distinguished COVID-19 pneumonia and Influenza-A viral pneumonia from 
healthy cases. Further, Shuai et al. [57] developed a system to extract the graphical 
features in order to provide a clinical diagnosis before pathogenic testing and thus 
save critical time. Also, Zheng et al. [58] developed a model for automatic detection 
using 3D CT volumes. Bai et al. [59] established and evaluated an AI system for 
differentiating COVID-19 and other pneumonia from chest CT to assess radiolo-
gist performance. As they have discussed, distinguishing COVID-19 from normal 
lung or other lung diseases, such as cancer from chest CT, may be straightforward. 
However, a major difficulty in controlling the current pandemic is making out 
subtle radiologic differences between COVID-19 and pneumonia of other origins. 
A total of 521 patients with positive RT-PCR results for COVID-19 and abnormal 
chest CT findings were retrospectively identified from 10 hospitals. A total of 665 
patients with non–COVID-19 pneumonia and definite evidence of pneumonia from 
chest CT were retrospectively selected from three hospitals.
Further, the authors have performed data augmentation dynamically during 
training and included flips, scaling, rotations, random brightness and contrast 
manipulations, random noise, and blurring. Training was performed for 20 epochs, 
where each epoch was defined as 16000 slices. A classification model was trained 
to distinguish between slices with and those without pneumonia-like findings 
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(both COVID-19 and non–COVID-19). In more technical details, the EfficientNet 
B4 architecture was used for the pneumonia classification task. Each slice was 
stacked to three channels as the input of EfficientNet that used pretrained weights 
on ImageNet. EfficientNets with dense top fully connected layers were used. There 
were four fully connected layers of 256, 128, 64, and 32 neurons, respectively. Also, 
a fully connected layer with 16 neurons with batch normalization and a classifica-
tion layer with sigmoid activation were added at the end of EfficientNet. Then, 
the slices were pooled using a two-layer fully connected neural network to make 
predictions at the patient level. Figure 10 shows the proposed classification neural 
network model, while Figure 11 demonstrates the model’s flowchart.
Kumar et al. [60] proposed a framework that collects a big amount of data from 
various hospitals and trains a deep learning model over a decentralized network 
using the most recent information related to COVID-19 patients based on CT slices. 
The authors suggested the integration of blockchain and federated-learning tech-
nology that allow the collection of data from different hospitals without the leakage 
of data; a step that adds the necessary privacy to the model. They employed Google’s 
Inception V3 network for feature extraction and tested various learning models 
(VGG, DenseNet, AlexNet, MobileNet, ResNet, and Capsule Network) in order 
Figure 10. 
Classification neural network model proposed by [59].
Figure 11. 
The flowchart showing the AI model used to distinguish COVID-19 from non–COVID-19 pneumonia. 
(PR AUC = precision recall area under curve, ROC AUC = receiver operator characteristics area under the 
curve) [59].
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to recognize the patterns from lung screening. They found that Capsule network 
achieved the best performance when compared to other learning models. Figure 12 
shows the suggested model in [60].
The Capsule network contains four layers: i) Convolutional layer, ii) Hidden 
layer, iii) PrimaryCaps layer, and iv) DigitCaps layer. A capsule is made when input 
features are in the lower layer. Each layer of the Capsule Network contains many 
capsules. To train it, the activation layer represents the parameters of the entity and 
computes the length of the Capsule network to re-compute the scores of the feature 
part. The capsule acts as a neuron. Capsule networks tend to describe an image at a 
component level and associate a vector with each component. The probability of the 
existence of a component is represented by the vectors lengths.
In federated learning, the hospitals keep their data private and share only the 
weights and gradients while blockchain technology is used to distribute the data 
securely among the hospitals. Federated learning was proposed by McMahan et al. 
[61] to learn from the shared model while protecting the privacy of data. In this 
context, the federated learning is used to secure data and aggregate the parameters 
from multiple organizations. As argued by the authors, since the volume of data 
is big, placing them on the blockchain directly with its limited storage space will 
be very expensive and resource-intensive. As such, a special data manipulation 
is needed. So, the hospital needs to store a transaction in the block to verify the 
ownership. The hospital data include the data type and size. It is noteworthy that 
federated learning does not affect the accuracy but it adds the privacy while sharing 
the data. Some selected 3D samples from the dataset are shown in Figure 13. The 
authors have claimed that the system sensitivity is 0.96, and its precision is 0.83. 
However, its specificity was not very attractive.
A simple 2D deep learning framework was developed in [62] to diagnose 
COVID-19 pneumonia based on a single chest CT image using transfer learning. 
For training and testing, the authors collected 3993 chest CT images of patients 
with COVID-19 pneumonia, other pneumonia and nonpneumonia diseases. 
These CT images were split into a training set and a testing set at a ratio of 8:2. 
After a simple preprocessing stage, three channels (256 × 256 × 3 pixels) were 
arranged in the input layer and fed into the pretrained model layers. In the pre-
trained model layers, the authors included one of these four models (VGG16, 
ResNet-50, Inception-v3, and Xception). Each model comprises two parts: a 
convolutional base and a classifier. The convolutional base is composed of a stack 
of convolutional and pooling layers to generate features from the images. The 
role of the classifier is to categorize the image based on the extracted features. 
The activations from the pretrained model layers were fed into the additional 
layers. In the additional layers, the activations were first flattened and connected 
to two fully connected layers: one consisted of 32 nodes, and the other consisted 
of three nodes. Subsequently, the activations from the second fully connected 
layer were fed into a SoftMax layer, which provided the probability for each of the 
Figure 12. 
COVID-19 model suggested by [60].
Simulation Modelling
16
classes (COVID-19, other pneumonia, and nonpneumonia). However, the study 
has several limitations as well. First, the testing dataset was obtained from the 
same sources as the training data set. This may raise issues of generalizability and 
overfitting of the models. Indeed, the authors have mentioned that the detection 
accuracy decreased when datasets from other published papers were used.
Song et al. [63] first extracted the main regions of the lungs and filled the blank 
of lung segmentation with the lung itself to avoid noise caused by different lung 
contours. Then, they extracted the top-K details in the CT images and obtained 
image-level predictions. Finally, the image-level predictions were combined to 
attain patient-level diagnoses. In the testing set, the model achieved an AUC of 0.95 
and sensitivity of 0.96. In [64], Jin et al. built a method to accelerate the diagnosis 
speed. This model was trained using 312 images. Yet, it achieved a comparable per-
formance with experienced radiologists. Among 1255 independent testing cases, the 
proposed deep-learning model achieved an accuracy of 94.98%, an AUC of 97.91%, 
a sensitivity of 94.06% and a specificity of 95.47%.
Zheng et al. [65] used U-Net to segment the lung area automatically, and then 
used 3DResNet for classification. As they have discussed, infectious areas can be 
distributed in many locations in the lungs, and automatic infectious area detec-
tion may not guarantee very high precision. Consequently, using the whole lung 
for classification is more convenient in practice. In [66], 3506 patients (468 with 
COVID-19, 1551 with CAP, and 1303 with non-pneumonia) were used to train and 
test another deep-learning model. The authors first used U-net to extract the whole 
lung region as an ROI. Afterwards, 2D RestNet50 was used for classifying COVID-
19. Since each CT scanning includes multiple 2D image slices, the features in the 
last layer of ResNet50 were max pooled and combined for prediction. The model 
achieved an AUC of 0.96 in classifying COVID-19 from CAP and other pneumonia. 
Moreover, Shi et al. [67] included 1658 patients with COVID-19 and 1027 patients 
with CAP for classification. They first used VBNet to segment the infected areas, 
bilateral lungs, 5 lung lobes, and 18 lung pulmonary areas. Then, hand-crafted 
features such as location specific features, infection size, and radiomic features were 
extracted, and least absolute shrinkage and selection operator (LASSO) was used 
for feature selection. The method reached sensitivity of 0.9, specificity of 0.8, and 
accuracy of 0.88.
Further, Dong et al. [68] reviewed the use of various imaging characteristics 
and computing models that have been applied for the management of COVID-19. 
Specifically, they have quantitatively analyzed the use of imaging data for detection 
Figure 13. 
Selected samples from [60].
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and treatment by means of CT, positron emission tomography - CT (PET/CT), lung 
ultrasound, and magnetic resonance imaging (MRI). PET is a sensitive but invasive 
imaging method that plays an important role in evaluating inflammatory and infec-
tious pulmonary diseases, monitoring disease progression and treatment effect, 
and improving patient management. It is worth mentioning that lung ultrasound 
is a non-invasive, radiation-free, and portable imaging method that allows for an 
initial bedside screening of low-risk patients, diagnosis of suspected cases in the 
emergency room setting, prognostic stratification, and monitoring of the changes 
in pneumonia [69, 70].
Also, Jin et al. [71] presented their experience in building and deploying an AI 
system that analyzes CT images and detects COVID-19 pneumonia features. They 
obtained the image samples from five different hospitals with 11 different models 
of CT equipment to increase the model’s generalization ability. The combined 
“segmentation - classification” model pipeline, can highlight the lesion regions 
in addition to the screening result. The model pipeline is divided into two stages: 
3D segmentation and classification. The pipeline leverages a model library that 
contains different segmentation models such as FCN-8 s, U-Net, V-Net, and 3D 
U-Net++, as well as the classification models like dual path network (DPN-92), 
Inception-v3, ResNet-50, and Attention ResNet-50. As for the training set, in 
addition to the positive cases, they assembled a set of negative images of inflam-
matory and neoplastic pulmonary diseases, such as lobar pneumonia, lobster 
pneumonia, and old lesions. Their aim was enabling the model to learn different 
COVID-19 features from various resources. Using 1136 training cases (723 positives 
for COVID-19), they were able to achieve a sensitivity of 0.974 and a specificity of 
0.922 on the test set. Further, the system achieved an AUC of 0.991. According to 
the authors, the system is in use in 16 hospitals and has a daily capacity of over 1300 
screenings. Similarly, Jin et al. [72] performed an extensive statistical analysis on CT 
images diagnosed by COVID-19.
They evaluated the system on a large dataset with more than 10000 CT volumes 
from COVID-19, influenza-A/B, non-viral CAP and non-pneumonia subjects. 
Figure 14 shows the workflow of the suggested system. The system consists of five 
key parts: (1) lung segmentation network, (2) slice diagnosis network, (3) COVID-
infectious slice locating network, (4) visualization module for interpreting the 
vital region, and (5) image phenotype analysis module for features explanation. CT 
volumes were divided into different cohorts. The authors claimed that the system 
achieved an AUC of 97.81% on a test set of 3199 scans.
Jin et al. [73] drafted a guideline according to the guidelines methodology 
and general rules of WHO in relation to CT imaging. This guideline includes the 
epidemiological characteristics, disease screening, diagnosis, treatment, and 
nosocomial infection prevention. In this regard, the authors have discussed that 
the imaging findings vary with the patient’s age, immunity status, disease stage at 
the time of scanning, underlying diseases, and drug interventions. The imaging 
features of lesions show: (1) dominant distribution (mainly subpleural, along the 
bronchial vascular bundles), (2) quantity (often more than three or more lesions, 
occasional single or double lesions), (3) shape (patchy, large block, nodular, lumpy, 
honeycomb-like or grid-like, cord-like, etc.), (4) density (mostly uneven, a paving 
stones-like change mixed with ground glass density and interlobular septal thicken-
ing, consolidation and thickened bronchial wall, etc.), and (5) concomitant signs 
variations (air-bronchogram, rare pleural effusion and mediastinal lymph nodes 
enlargement, etc.).
In addition, Chen et al. [74] constructed a system based on deep learning for 
detecting COVID-19 pneumonia from high resolution CT. For model development 
and validation, 46096 anonymous images from 106 admitted patients, including 51 
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patients of laboratory confirmed COVID-19 pneumonia and 55 control patients of 
other diseases in Renmin Hospital of Wuhan University were retrospectively col-
lected and processed. Twenty-seven consecutive patients who underwent CT scans 
were prospectively collected to evaluate and compare the efficiency of radiologists 
against COVID-19 pneumonia with that of the model. The authors have first filtered 
the images where 35355 images were selected and split into training and testing 
datasets. In more detail, the authors implemented UNet++ being a well-known 
architecture for medical image segmentation. They trained UNet++ to extract 
valid areas in CT images using 289 randomly selected CT images and tested it on 
other 600 randomly selected CT images. The training images were labeled with the 
smallest rectangle containing all valid areas. With the raw CT scan images taken as 
the input, and the labeled map from the expert as the output, UNet++ was used to 
train in an image-to-image manner. The model successfully extracted valid areas in 
600 images from the testing set with an accuracy of 100%. Based on system per-
formance, the authors constructed a cloud-based platform to provide a worldwide 
assistance for detecting COVID-19 pneumonia [75].
In [76], Vinod and Prabaharan have elaborated a methodology that helps 
identifying COVID-19 infected people among the normal individuals by utiliz-
ing CT scan. The image diagnosis tool utilizes decision tree classifier for finding 
Coronavirus infected person. The percentage accuracy of an image was analyzed 
in terms of precision, recall score and F1 score. Moreover, Gieraerts et al. [77] 
hypothesized that the use of semi-automated AI may allow for more accurate 
patient detection. They assessed COVID-19 patients who underwent chest CT by 
conventional visual and AI-based quantification of lung injury. They also studied 
the impact of chest CT variability in determining the potential response to novel 
antiviral therapies. In their study, 250 consecutive patients with clinical suspicion 
of COVID-19 pneumonia were tested with both RT-PCR and CT within a 2-hour 
Figure 14. 
The workflow of the AI system suggested in [72].
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interval of hospital admission. Epidemiological, demographic, clinical, and 
laboratory data at admission were obtained from the electronic patient manage-
ment system.
In Zhang et al. [78], 4695 manually annotated CT slices were used to build 
seven classes, including background, lung field, consolidation, ground-glass 
opacity, pulmonary fibrosis, interstitial thickening, and pleural effusion. After 
a comparison between different semantic segmentation approaches, the authors 
selected DeepLabv3 as the segmentation detection backbone. The diagnostic system 
was based on a neural network fed by the lung-lesion maps. The results showed a 
COVID-19 diagnostic accuracy of 92.49% when tested on 260 subjects. In Bai et al. 
[79], a direct classification of COVID-19 specific pneumonia versus other etiologies 
was performed using an EfficientNet B5 network followed by a two-layer fully con-
nected network to pool the information from multiple slices and provide a patient-
level diagnosis. This system yielded 96% accuracy on a testing set of 119 subjects 
compared to an average accuracy of 85% for six radiologists.
Also, Ying et al. [80] used 2D slices including lung regions segmented by OpenCV. 
Fifteen slices of complete lungs were derived from each 3D chest CT images, and each 
2D slice was used as the input to the system. A pretrained ResNet-50 was used and the 
Feature Pyramid Network (FPN) was added to extract the top-K details from each 
image. An attention module was coupled to learn the important details. Chest CT 
images from 88 patients with COVID-19, 101 patients with bacterial pneumonia, and 
86 healthy persons were used. The model achieved an accuracy of 86% for pneu-
monia classification (COVID-19 or bacterial pneumonia), and an accuracy of 94% 
for pneumonia diagnosis (COVID-19 or healthy). Wang et al. [81] used 1065 chest 
CT scan images of COVID-19 patients to build a classifier using InceptionNet. They 
reported an accuracy of 89.5%, a specificity of 0.88, and a sensitivity of 0.87. In [82], 
different deep learning approaches (VGG16, InceptionResNetV2, ResNet50, VGG19, 
MobilenetV2, and NasNetMobile) have been modified and tested on 400 CT scan 
images. The results have shown that NasNetMobile outperformed all other models 
in terms of accuracy (81.5% –95.2%). On the other hand, Mucahid et al. [83] used 
classical feature extraction techniques for COVID-19 detection. For example, they 
have implemented gray level co-occurrence matrices (GLCM), local directional pat-
tern (LDP), gray-level run length matrix (GLRLM), and discrete wavelet transform 
(DWT). They reported an accuracy of 99.68% in the best configuration settings.
Modegh et al. [84] proposed a system to distinguish healthy people, patients 
with COVID-19, and patients with other pneumonia diseases from axial lung 
CT-scan images. The general workflow for the proposed model is shown in  
Figure 15. The Ground Glass Opacity Axial (GGOA) CT-scan images are prepro-
cessed and the lobes of the lungs are detected and extracted from the axial slices. 
The images of the left and right lobes of all the slices are then fed into two deep 
CNNs, one for calculating the probability of being diseased versus healthy, and the 
other for calculating the probability of diagnosis to be COVID-19 versus other dis-
eases. In addition, the system detects the infected areas in the lung images. At the 
end, the probabilities assigned to the lobes are aggregated to make a final decision.
Figure 16 shows the model used for calculating the probability of each slice 
lobe being infected. The model was evaluated on a dataset of 3359 samples from 
6 different medical centers and achieved sensitivities of 97.8% and 98.2%, and 
specificities of 87% and 81% in distinguishing normal cases from the diseased 
and COVID-19 from other diseases, respectively. Authors in [85] examined the 
effect of generalizability of the deep learning models, given the heterogeneous 
factors in training datasets such as patient demographics and pre-existing clinical 
conditions. The examination was done by evaluating the classification models 
trained to identify COVID-19 positive patients on 3D CT datasets from different 
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countries: UT Southwestern (UTSW), CC-CCII Dataset (China), COVID-CTset 
(Iran), and MosMedData (Russia). The data were divided into two classes: 
COVID-19 positive and COVID-19 negative patients. The models trained on a 
Figure 15. 
The general workflow for the interpretable COVID-19 detection proposed in [84].
Figure 16. 
The deep model used for calculating the probability of each slice lobe [84].
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single dataset achieved accuracy/AUC values of 0.87/0.826 (UTSW), 0.97/0.988 
(CC-CCCI), and 0.86/0.873 (COVID-CTset) when evaluated on their own 
dataset.
In addition, Shah et al. [86] developed a deep learning network (CTnet-10) for 
COVID-19 classification. The model is fed with an input image of size 128 × 128 × 3. 
It passes through two convolutional blocks of dimensions 126 × 126 × 32, 
124 × 124 × 32 respectively. Then it passes through a max-pooling of dimension 
62 × 62 × 32 followed by two convolutional layers of dimensions 60 × 60 × 32, 
58 × 58 × 32 respectively. Then, it is passed through a pooling layer of dimension 
29 × 29 × 32, a flattened layer of 26912 neurons, and dropout layers of 256 neurons. 
After that, it is passed through a dense layer of a single neuron, where the CT 
scan image is classified as COVID-19 positive or negative. The system achieved an 
accuracy of 82.1%. The CTnet-10 model architecture is shown in Figure 17.
VB-Net, a deep learning network, was developed by Shan et al. [87] to quantify 
longitudinal changes in the follow-up CT scans of COVID-19 patients, and to 
explore the quantitative lesion distribution. VB-Net is a modified 3D CNN that 
consists of two paths. The first is a contracting path including down-sampling and 
convolution operations to extract global image features. The second is an expansive 
path including up-sampling and convolution operations to integrate fine-grained 
image features. Compared with V-Net, the VB-Net is much faster. The system not 
only performs auto-contouring of infection regions, but also accurately estimates 
their shapes, volumes and percentage of infection (POI) in CT scans. In addition, 
it measures the severity of COVID-19 and the distribution of infection within the 
lung. The accurate segmentation provides quantitative information that is necessary 
Figure 17. 
CTnet-10 model architecture [86].
Figure 18. 




Typical infection segmentation results of CT scans for three COVID-19 patients. Rows 1–3: Early, progressive 
and severe stages. Columns 1–3: CT image, CT images overlaid with segmentation, and 3D surface rendering of 
segmented infections [87].
to track disease progression and analyze longitude changes of COVID-19 during 
the entire treatment period. After segmentation, various metrics are computed to 
quantify the infection, including the volumes of infection in the whole lung, and 
the volumes of infection in each lobe and each bronchopulmonary segment.
The system was trained using 249 COVID- 19 patients, and validated using 300 
new COVID-19 patients. To accelerate the manual delineation of CT images for 
training, a human-in-the-loop (HITL) strategy (shown in Figure 18) was adopted 
to assist radiologists to refine automatic annotation of each case. To evaluate 
the performance of the system, the Dice similarity coefficient, the differences 
of volume and the POI were calculated between the automatic and the manual 
Figure 19. 
The proposed pipeline for quantifying COVID-19 infection [87].
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segmentation results on the validation set. The system yielded a Dice similarity 
coefficient of 91.6% and a mean POI estimation error of 0.3% for the whole lung on 
the validation dataset. Moreover, the proposed HITL strategy reduced the delinea-
tion time to 4 minutes after 3 iterations of model updating, compared to the cases of 
fully manual delineation that often take 1 to 5 hours. Figure 19 shows the pipeline 
for quantifying COVID-19 infection, whereas Figure 20 shows typical infection 
segmentation results of CT scans for three COVID-19 patients.
4. Discussion
The specific nature of COVID-19 pandemic requires strong coordination of con-
nected data, people, and systems to facilitate worldwide collaboration in fighting 
against it. From this study, we notice that healthcare stakeholders are not using the 
same systems, data formats, or standards. This can obstruct the ability to identify 
the possible trends of solutions to the pandemic related challenges and develop 
interventions among the associated efforts. Public health researchers, epidemiolo-
gists, and government officials need to be connected via integrated systems with 
connected data to understand the evolving pandemic better and make collective 
decisions on addressing this crisis. An important key action that needs to be taken to 
ensure best possible fight of the current (or even future) pandemic(s) is to catalyze 
scaling up the implementation of AI and ML in health sector.
Our study specifically suggests the following important issues that need to be 
addressed intensely and more efficiently:
• Due to the low contrast of the infection regions in some images and large varia-
tion of both shape and position across different patients, delineating the infec-
tion regions from the chest images is very challenging [88, 89]. Researchers are 
challenged to investigate AI techniques that may help in this direction.
• Although CT provides rich pathological information, it was noticed that in 
some cases only qualitative evaluation has been provided and precise changes 
across follow-up CT scans are often ignored. Actually, contouring infection 
regions in the Chest CT is necessary for quantitative assessment [90, 91]. As 
such, more investigation is required in this area.
• Quantifying imaging metrics and correlating them with syndromes, epidemi-
ology, and treatment responses is essential and could further reveal insights 
about imaging markers and findings toward improved diagnosis and treatment 
for COVID-19 [92, 93].
• Some segmentation models were trained using imperfect ground-truth data. 
This could be improved by using 3D segmentation networks and adopting 
precise ground-truth annotated by experts [94, 95].
• The images in some datasets were acquired from different devices. This 
situation makes the classification process a kind of challenging. This could 
be explained by the fact that some gray-levels in one image represent certain 
Coronavirus infected levels, and the same gray-levels in another image may 
represent different levels (may lead to different decisions) [96, 97].
• Some systems were developed to quantify infections only, and it may not be 




• Many datasets were collected in one center, which may not be representative of 
all COVID-19 patients in other geographic areas. The generalization of the deep 
learning system needs to be further validated on multi-center datasets [100].
• Experimental evidence is presented on datasets of hundreds (maybe thousands). 
However, the need is to go to real world settings, in which databases consist of 
hundreds of thousands and even more cases, with large variability [101].
5. Conclusion
The COVID-19 is a disease that has spread all over the world. This work 
attempted to provide a detailed study on how the AI and ML can help in various 
domains related to COVID-19, specifically in the area of disease diagnosis using CT 
imagery. In pursuing so, we considered, examined, discussed, and analyzed com-
prehensive studies and detailed researches proposed by intellectuals and researchers 
from various scientific communities and international academic institutions. Deep 
learning techniques and algorithms have shown immense appearances and imple-
mentations in different domains and COVID-19 related applications.
AI solutions have the potential to detect and analyze any abnormalities in health 
conditions in general, and related to COVID-19 in particular. The study has demon-
strated that AI solutions can assist in differentiating Coronavirus patients from those 
who do not have the disease and can provide support in tracking disease progression. 
AI technology can potentially support radiologists in the triage, quantification, 
and trend analysis of data. For example, if the developed technique suggests a 
significantly increased likelihood of disease, then the case can be flagged for further 
review by a radiologist or clinician for possible treatment/quarantine. Moreover, AI 
technology can provide a consistent method for rapid evaluation of high volumes of 
diagnostic that can reliably exclude images which are negative for findings associated 
with COVID-19. This decreases the volume of cases passing through to the radiologist 
without overlooking positive cases. Using AI solutions, progression and regression of 
positive findings could be monitored more quantitatively and regularly. This could 
lead to more effective identification and containment of early cases. The study also 
discovered that a critical existing impediment to effective AI implementation is the 
lack of COVID-19-related clinical data that can be maintained and processed into 
easily accessible databases. Integrating COVID-19-related clinical data with existing 
biobanks, as well as pre-existing patient data, could help bioinformaticians and com-
putational scientists develop a faster and more practical way to useful data-mining.
It is our hypothesis that AI and ML tools can leverage the ability to modify and 
adapt existing models and combine them with initial clinical understanding to 
address COVID-19 challenges and the new emerging strains or mutations of the virus. 
Researchers and scientists are hoping to speed up the development of extremely 
precise and useful AI, ML, and deep learning technologies to combat COVID-19. If 
our societies could not reach the best expected AI solutions during this pandemic, we 
strongly anticipate that AI technology will be of greater help with the next pandemic.
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